These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35946207)

  • 21. Optimal ex vivo lung perfusion techniques with oxygenated perfusate.
    Noda K; Tane S; Haam SJ; Hayanga AJ; D'Cunha J; Luketich JD; Shigemura N
    J Heart Lung Transplant; 2017 Apr; 36(4):466-474. PubMed ID: 27914896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Conversional Efficacy of Ex Vivo Lung Perfusion and Clinical Outcomes in Patients Undergoing Transplantation of Donor Lungs by Ex Vivo Lung Perfusion: A Meta-Analysis.
    Luo Q; Zhu L; Wang Y; Wang L; Lv W; Hu J
    Ann Transplant; 2019 Dec; 24():647-660. PubMed ID: 31879416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion.
    Andreasson ASI; Borthwick LA; Gillespie C; Jiwa K; Scott J; Henderson P; Mayes J; Romano R; Roman M; Ali S; Fildes JE; Marczin N; Dark JH; Fisher AJ;
    J Heart Lung Transplant; 2017 Sep; 36(9):985-995. PubMed ID: 28551353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. α
    Lin H; Chen M; Tian F; Tikkanen J; Ding L; Andrew Cheung HY; Nakajima D; Wang Z; Mariscal A; Hwang D; Cypel M; Keshavjee S; Liu M
    J Heart Lung Transplant; 2018 May; 37(5):656-666. PubMed ID: 29153638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic and Therapeutic Implications of Ex Vivo Lung Perfusion in Lung Transplantation: Potential Benefits and Inherent Limitations.
    Yu J; Zhang N; Zhang Z; Li Y; Gao J; Chen C; Wen Z
    Transplantation; 2023 Jan; 107(1):105-116. PubMed ID: 36508647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of metabolomics to identify strategies to improve and prolong ex vivo lung perfusion for lung transplants.
    Shin J; Hsin MK; Baciu C; Chen Y; Zamel R; Machuca T; Yeung J; Cypel M; Keshavjee S; Liu M
    J Heart Lung Transplant; 2021 Jun; 40(6):525-535. PubMed ID: 33849769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
    Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
    Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technical Advances Targeting Multiday Preservation of Isolated Ex Vivo Lung Perfusion.
    Iskender I
    Transplantation; 2024 Jun; 108(6):1319-1332. PubMed ID: 38499501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung transplantation after ex vivo lung perfusion in two Scandinavian centres.
    Nilsson T; Wallinder A; Henriksen I; Nilsson JC; Ricksten SE; Møller-Sørensen H; Riise GC; Perch M; Dellgren G
    Eur J Cardiothorac Surg; 2019 Apr; 55(4):766-772. PubMed ID: 30376058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Male versus female inflammatory response after brain death model followed by ex vivo lung perfusion.
    Ricardo-da-Silva FY; Armstrong-Jr R; Ramos MMA; Vidal-Dos-Santos M; Jesus Correia C; Ottens PJ; Moreira LFP; Leuvenink HGD; Breithaupt-Faloppa AC
    Biol Sex Differ; 2024 Jan; 15(1):11. PubMed ID: 38287395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ex Vivo Lung Perfusion Improves the Inflammatory Signaling Profile of the Porcine Donor Lung Following Transplantation.
    Stone JP; Ball AL; Crichley W; Yonan N; Liao Q; Sjöberg T; Steen S; Fildes JE
    Transplantation; 2020 Sep; 104(9):1899-1905. PubMed ID: 32502131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of ex vivo lung perfusion on storage of isolated lungs.
    Liu F; Lu Y; Wei D; Lin X; Yang Z; Mao Y; Chen J
    Ann Palliat Med; 2020 Mar; 9(2):359-367. PubMed ID: 32233631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress of Clinical Application for Ex Vivo Lung Perfusion (EVLP) in Lung Transplantation.
    Gu C; Pan X; Shi J
    Methods Mol Biol; 2020; 2204():217-224. PubMed ID: 32710328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternative solution for ex vivo lung perfusion, experimental study on donated human lungs non-accepted for transplantation.
    Fernandes LM; Mariani AW; Medeiros IL; Samano MN; Abdalla LG; Correia AT; Nepomuceno NA; Canzian M; Pêgo-Fernandes PM
    Acta Cir Bras; 2015 May; 30(5):359-65. PubMed ID: 26016936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ex-vivo lung perfusion.
    Moreno Garijo J; Roscoe A
    Curr Opin Anaesthesiol; 2020 Feb; 33(1):50-54. PubMed ID: 31688085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reconditioning of lungs donated after circulatory death with normothermic ex vivo lung perfusion.
    Nakajima D; Chen F; Yamada T; Sakamoto J; Ohsumi A; Bando T; Date H
    J Heart Lung Transplant; 2012 Feb; 31(2):187-93. PubMed ID: 22305381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplant Suitability of Rejected Human Donor Lungs With Prolonged Cold Ischemia Time in Low-Flow Acellular and High-Flow Cellular Ex Vivo Lung Perfusion Systems.
    Okamoto T; Wheeler D; Farver CF; McCurry KR
    Transplantation; 2019 Sep; 103(9):1799-1808. PubMed ID: 30801532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donation After Circulatory Death Lungs Transplantable Up to Six Hours After Ex Vivo Lung Perfusion.
    Charles EJ; Huerter ME; Wagner CE; Sharma AK; Zhao Y; Stoler MH; Mehaffey JH; Isbell JM; Lau CL; Tribble CG; Laubach VE; Kron IL
    Ann Thorac Surg; 2016 Dec; 102(6):1845-1853. PubMed ID: 27614736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of ex vivo lung perfusion on brain-dead donor lung utilization: The French experience.
    Abdoul N; Legeai C; Cantrelle C; Mercier O; Olland A; Mordant P; Thomas PA; Jougon J; Tissot A; Maury JM; Sage E; Dorent R
    Am J Transplant; 2022 May; 22(5):1409-1417. PubMed ID: 35000283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profiling inflammation and tissue injury markers in perfusate and bronchoalveolar lavage fluid during human ex vivo lung perfusion.
    Andreasson AS; Karamanou DM; Gillespie CS; Özalp F; Butt T; Hill P; Jiwa K; Walden HR; Green NJ; Borthwick LA; Clark SC; Pauli H; Gould KF; Corris PA; Ali S; Dark JH; Fisher AJ
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):577-586. PubMed ID: 28082471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.